Education + Advocacy = Change

Click a topic below for an index of articles:

 

New-Material

Home

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

 

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

      

Dermatology 1996;193(1):65-66

Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection.

Simsek H, Savas C, Akkiz H, Telatar H Hacettepe University Medical School, Department of Internal Medicine, Ankara, Turkey.

http://www.hepatitis-central.com/Hepatitis C Virus/ifn/vitiligo.html

Vitiligo is an autoimmune disease characterized by depigmentation of the skin due to destruction of melanocytes. Interferons have been used for the treatment of chronic hepatitis C and some malignancies. We report interferon alpha-2a-induced vitiligo in a male patient with chronic active hepatitis C. All skin lesions disappeared completely without requiring therapy after discontinuation of interferon. This case suggests that vitiligo may be developed during interferon therapy as a side effect.

    

Publication Types:

Review Review of reported cases

PMID: 8864627, UI: 97018010